Spec. MD.
Birkan Alaycı
Liv Hospital Vadistanbul
Internal Medicine
Hospital
Please Select Hospital!
Choose Department
All Branches
Before Noon
Afternoon
You must select a hospital to make an appointment.
You can call our Call Center at 444 4 548 for available appointment slots and information.
Areas of Interests
- Obesity and Metabolic Syndrome
- Diabetes and Insulin Resistance
- Cholesterol and Lipid Disorders
- Fatty Liver Disease
- Thyroid Diseases
- Bone Metabolism and Vitamin D
- Hypertension
- Chronic Fatigue and Unexplained Weakness
- Iron Deficiency and Anemia
- Chronic Disease Monitoring
- Irritable Bowel Syndrome
- Exercise and Metabolism
- Geriatric Patient Monitoring
- Preventive Health and Check-Up
Education:
- Dokuz Eylül University Faculty of Medicine, 2018
- Health Sciences University Şişli Hamidiye Etfal Health Application and Research Center, Internal Medicine Specialization, 2023
Experience:
- Liv Hospital Vadistanbul, from November 2025
- Artvin Ardanuç District State Hospital, 2023–2025
Publications:
- Alayci B. When Trimethoprim-Sulfamethoxazole Turns Pernicious: Type 4 Renal Tubular Acidosis in a Diabetic Patient With Sjögren's Syndrome. Cureus, 2025.
- Alayci B. Frequency of Metabolic Syndrome in Paget's Disease of Bone. Medical Bulletin of Sisli Etfal Hospital, 2022.
Ongoing Academic Studies:
- Alayci B. Association between Serum 25-Hydroxyvitamin D Levels and Parathyroid Hormone in Adults with Hypovitaminosis D and Preserved Renal Function: A Retrospective Cross-Sectional Study
- Alayci B, Gerçek ÖZ. Composition of Weight Loss Associated with Incretin-Based Therapy: A Systematic Review and Meta-Analysis of DXA-Measured Lean and Fat Mass in Randomized Controlled Trials
Refereeing Experience:
- Irish Journal of Medical Science (Indexed in Web of Science)
- Cureus
- TİHUD — Turkish Internal Medicine Specialists Association
- EFIM — European Federation of Internal Medicine
- EFIM — Young Internists
- ACP — American College of Physicians
Ask our Experts!
You can contact with our experts for your questions!
Success!
